Stage IV Cutaneous Melanoma AJCC v6 and v7 Active Not Recruiting Phase 1 Trials for Hydrogen (DB15127)

IndicationStatusPhase
DBCOND0091050 (Stage IV Cutaneous Melanoma AJCC v6 and v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01364051Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid MalignanciesTreatment